Drugs / BENCYCLOQUIDIUM
BENCYCLOQUIDIUM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05038202 | Jun 2021 → Apr 2024 | allergic rhinitis | Yingu Pharmaceutical Co., Ltd | Unknown | Met primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BENCYCLOQUIDIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596085 ↗ |
| Known as | BCQB | “bencycloquidium bromide (BCQB) nasal spray” PMID 39746515 ↗ Dec 2024 |
| Known as | Bencycloquidium Bromide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05038202 ↗ |
| Modality | Small molecule | — CHEMBL4596085 ↗ |
| Route | Intranasal | “nasal spray” NCT05038202 ↗ |